Sensus Healthcare Inc (SRTS)
5.82
-0.12
(-2.02%)
USD |
NASDAQ |
May 22, 16:00
5.82
0.00 (0.00%)
After-Hours: 20:00
Sensus Healthcare Research and Development Expense (Quarterly): 0.926M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.926M |
December 31, 2023 | 0.677M |
September 30, 2023 | 1.083M |
June 30, 2023 | 0.822M |
March 31, 2023 | 1.098M |
December 31, 2022 | 1.158M |
September 30, 2022 | 0.746M |
June 30, 2022 | 0.827M |
March 31, 2022 | 0.728M |
December 31, 2021 | 1.106M |
September 30, 2021 | 0.744M |
June 30, 2021 | 0.925M |
March 31, 2021 | 0.661M |
December 31, 2020 | 0.843M |
September 30, 2020 | 0.941M |
June 30, 2020 | 1.148M |
March 31, 2020 | 1.225M |
December 31, 2019 | 0.9497M |
September 30, 2019 | 1.568M |
Date | Value |
---|---|
June 30, 2019 | 1.935M |
March 31, 2019 | 1.966M |
December 31, 2018 | 1.485M |
September 30, 2018 | 1.713M |
June 30, 2018 | 1.565M |
March 31, 2018 | 1.498M |
December 31, 2017 | 1.695M |
September 30, 2017 | 1.501M |
June 30, 2017 | 1.159M |
March 31, 2017 | 1.135M |
December 31, 2016 | 0.7274M |
September 30, 2016 | 0.3898M |
June 30, 2016 | 0.4136M |
March 31, 2016 | 0.2934M |
December 31, 2015 | 0.3343M |
September 30, 2015 | 0.3585M |
June 30, 2015 | 0.3341M |
March 31, 2015 | 0.4398M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.661M
Minimum
Mar 2021
1.935M
Maximum
Jun 2019
1.006M
Average
0.9335M
Median
Research and Development Expense (Quarterly) Benchmarks
Perspective Therapeutics Inc | 7.452M |
Retractable Technologies Inc | 0.1423M |
Xtant Medical Holdings Inc | 0.527M |
Asensus Surgical Inc | 8.091M |
Catheter Precision Inc | 0.037M |